These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 21955364

  • 1. Quantifying cannabis use with the timeline followback approach: a psychometric evaluation.
    Norberg MM, Mackenzie J, Copeland J.
    Drug Alcohol Depend; 2012 Mar 01; 121(3):247-52. PubMed ID: 21955364
    [Abstract] [Full Text] [Related]

  • 2. Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use.
    Robinson SM, Sobell LC, Sobell MB, Leo GI.
    Psychol Addict Behav; 2014 Mar 01; 28(1):154-62. PubMed ID: 23276315
    [Abstract] [Full Text] [Related]

  • 3. The Cannabis Problems Questionnaire: factor structure, reliability, and validity.
    Copeland J, Gilmour S, Gates P, Swift W.
    Drug Alcohol Depend; 2005 Dec 12; 80(3):313-9. PubMed ID: 15916867
    [Abstract] [Full Text] [Related]

  • 4. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off.
    Martin G, Copeland J, Gates P, Gilmour S.
    Drug Alcohol Depend; 2006 Jun 09; 83(1):90-3. PubMed ID: 16310973
    [Abstract] [Full Text] [Related]

  • 5. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults.
    Bashford J, Flett R, Copeland J.
    Addiction; 2010 Apr 09; 105(4):615-25. PubMed ID: 20403014
    [Abstract] [Full Text] [Related]

  • 6. Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU).
    Cuttler C, Spradlin A.
    PLoS One; 2017 Apr 09; 12(5):e0178194. PubMed ID: 28552942
    [Abstract] [Full Text] [Related]

  • 7. Psychometric properties of the CAST and SDS scales in young adult cannabis users.
    Cuenca-Royo AM, Sánchez-Niubó A, Forero CG, Torrens M, Suelves JM, Domingo-Salvany A.
    Addict Behav; 2012 Jun 09; 37(6):709-15. PubMed ID: 22386300
    [Abstract] [Full Text] [Related]

  • 8. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H, Mabila JD, Chauchard E, Mantoulan R, Rousseau A.
    Encephale; 2008 Jan 09; 34(1):8-16. PubMed ID: 18514145
    [Abstract] [Full Text] [Related]

  • 9. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial.
    Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM.
    Drug Alcohol Depend; 2018 Jan 01; 182():1-7. PubMed ID: 29112827
    [Abstract] [Full Text] [Related]

  • 10. Behavioral assessment of gambling: an application of the timeline followback method.
    Weinstock J, Whelan JP, Meyers AW.
    Psychol Assess; 2004 Mar 01; 16(1):72-80. PubMed ID: 15023094
    [Abstract] [Full Text] [Related]

  • 11. The Adolescent Cannabis Problems Questionnaire (CPQ-A): psychometric properties.
    Martin G, Copeland J, Gilmour S, Gates P, Swift W.
    Addict Behav; 2006 Dec 01; 31(12):2238-48. PubMed ID: 16626880
    [Abstract] [Full Text] [Related]

  • 12. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S, Aubry JM, Gex-Fabry M, Ragama-Pardos E, McQuillan A, Bertschy G.
    Encephale; 2003 Dec 01; 29(6):499-505. PubMed ID: 15029084
    [Abstract] [Full Text] [Related]

  • 13. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.
    Connor JP, Gullo MJ, Feeney GF, Young RM.
    Drug Alcohol Depend; 2011 Jun 01; 115(3):167-74. PubMed ID: 21163593
    [Abstract] [Full Text] [Related]

  • 14. The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users.
    Martin G, Copeland J, Swift W.
    J Subst Abuse Treat; 2005 Oct 01; 29(3):207-13. PubMed ID: 16183469
    [Abstract] [Full Text] [Related]

  • 15. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis.
    Hides L, Dawe S, Young RM, Kavanagh DJ.
    Addiction; 2007 Jan 01; 102(1):35-40. PubMed ID: 17207121
    [Abstract] [Full Text] [Related]

  • 16. Cannabis-related deficits in real-world memory.
    Montgomery C, Seddon AL, Fisk JE, Murphy PN, Jansari A.
    Hum Psychopharmacol; 2012 Mar 01; 27(2):217-25. PubMed ID: 22389086
    [Abstract] [Full Text] [Related]

  • 17. Development of a short cannabis problems questionnaire for adolescents in the community.
    Proudfoot H, Vogl L, Swift W, Martin G, Copeland J.
    Addict Behav; 2010 Jul 01; 35(7):734-7. PubMed ID: 20356683
    [Abstract] [Full Text] [Related]

  • 18. Development of the Treatment Outcomes Profile.
    Marsden J, Farrell M, Bradbury C, Dale-Perera A, Eastwood B, Roxburgh M, Taylor S.
    Addiction; 2008 Sep 01; 103(9):1450-60. PubMed ID: 18783500
    [Abstract] [Full Text] [Related]

  • 19. Multimethod alexithymia assessment in adolescents and young adults with a cannabis use disorder.
    Dorard G, Berthoz S, Haviland MG, Phan O, Corcos M, Bungener C.
    Compr Psychiatry; 2008 Sep 01; 49(6):585-92. PubMed ID: 18970907
    [Abstract] [Full Text] [Related]

  • 20. Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial.
    Hjorthøj CR, Fohlmann A, Larsen AM, Arendt M, Nordentoft M.
    Addiction; 2012 Jun 01; 107(6):1123-31. PubMed ID: 22151583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.